Neurexis Therapeutics


Neurexis is developing an optimized peptide with demonstrated efficacy and safety in small and large animal models of global cerebral ischemia.

Industries

Employees

1-10

Links


Org chart

Michael Artinger
CEO & Board Member
Collapse
Ulli Bayer
CSO & Board Member
Olivia Buonarati Asfaha
Chief Operating Officer
Olivia Asfaha
Chief Operating Officer


Offices